BioCentury | Dec 31, 2020
Distillery Therapeutics

SIRT5 overexpression could rescue mitochondrial disease induced by SUCLA2 mutations

...for Research on Aging, Novato, Calif.email: everdin@buckinstitute.orgCONTACT: Anu Suomalainen, University of Helsinki, Helsinki, Finlandemail: anu.wartiovaara@helsinki.fi Claire Quang Gladstone Institutes University of California San Francisco University of Helsinki Buck...
BioCentury | Nov 6, 2020
Targets & Mechanisms

Data Byte: newly identified host factors that regulate ACE2 expression

...led by German Center for Neurodegenerative Diseases and University of Helsinki...
...of MIT and Harvard German Center for Neurodegenerative Diseases University of Helsinki University...
BioCentury | Jun 18, 2020
Finance

June 17 Quick Takes: Constellation, Celldex raise follow-ons; plus CureVac quiet on IPO chatter and venture cash for GreenLight, TILT, DiogenX

...U.S. Phase I trials and prepare for Phase II testing. The seven-year-old spinout from the University of Helsinki...
BioCentury | Feb 14, 2020
Targets & Mechanisms

Entrepreneur watch: Iwasaki targets the lymphatic system to clear brain tumors

...Associate Editor Yale School of Medicine Yale University Institut National de la Sante et de la Recherche Medicale (INSERM) University of Helsinki Howard...
BioCentury | Dec 6, 2019
Targets & Mechanisms

Emerging immuno-oncology mechanisms at ASH 2019

...who achieved remission compared with those who had not ( No. 660 ). Work by University of Helsinki...
...box Allison Johnson, Senior Writer Inarigivir soproxil (sb 9200) American Society of Hematology Northwestern University University Health Network Kumamoto University Harvard Medical School University of Helsinki Technical...
BioCentury | Sep 13, 2019
Emerging Company Profile

Valo: adding tumor antigens to oncolytic viruses

...viruses to display tumor antigens. Scientific founder and board member Vincenzo Cerullo, a professor at University of Helsinki...
...Peptide-coated Conditionally Replicating Adenovirus (PeptiCRAd),which was Valo’s core IP when it spun out of the University of Helsinki...
...viral surfaces Disease focus: Cancer Clinical status: Preclinical Founded: 2016 by Vincenzo Cerullo University collaborators: University of Helsinki...
BioCentury | Aug 8, 2019
Distillery Therapeutics

Activating WNT signaling to regenerate aged or damaged intestinal epithelium

...10, 2019 doi:10.1038/s41586-019-1383-0 CONTACT: Pekka Katajisto, University of Helsinki, Helsinki, Finland; Karolinksa Institute, Stockholm, Sweden email: pekka.katajisto@helsinki.fi Claire Quang University of Helsinki Notum...
BioCentury | Aug 8, 2018
Distillery Therapeutics

Cardiovascular

...published online June 25, 2018 doi:10.1073/pnas.1722317115 CONTACT: Pipsa Saharinen, University of Helsinki, Helsinki, Finland email: pipsa.saharinen@helsinki.fi Chris Lieu University of Helsinki Integrin...
BioCentury | Jul 20, 2018
Company News

U of Helsinki grants Herantis rights to a non-invasive CDNF approach

...PD patients. University of Helsinki, Helsinki, Finland Herantis Pharma plc (HSE:HRTIS), Helsinki, Finland Business: Neurology Shannon Lehnbeuter Herantis Pharma plc University of Helsinki Cerebral...
BioCentury | Jun 12, 2018
Preclinical News

Investors skittish again over preclinical CRISPR studies

...10 (LCA10). Allison Johnson CRISPR Therapeutics AG Editas Medicine Inc. Intellia Therapeutics Inc. Karolinska Institute Novartis Institute for Biomedical Research University of Cambridge University of Helsinki p53...
Items per page:
1 - 10 of 50
BioCentury | Dec 31, 2020
Distillery Therapeutics

SIRT5 overexpression could rescue mitochondrial disease induced by SUCLA2 mutations

...for Research on Aging, Novato, Calif.email: everdin@buckinstitute.orgCONTACT: Anu Suomalainen, University of Helsinki, Helsinki, Finlandemail: anu.wartiovaara@helsinki.fi Claire Quang Gladstone Institutes University of California San Francisco University of Helsinki Buck...
BioCentury | Nov 6, 2020
Targets & Mechanisms

Data Byte: newly identified host factors that regulate ACE2 expression

...led by German Center for Neurodegenerative Diseases and University of Helsinki...
...of MIT and Harvard German Center for Neurodegenerative Diseases University of Helsinki University...
BioCentury | Jun 18, 2020
Finance

June 17 Quick Takes: Constellation, Celldex raise follow-ons; plus CureVac quiet on IPO chatter and venture cash for GreenLight, TILT, DiogenX

...U.S. Phase I trials and prepare for Phase II testing. The seven-year-old spinout from the University of Helsinki...
BioCentury | Feb 14, 2020
Targets & Mechanisms

Entrepreneur watch: Iwasaki targets the lymphatic system to clear brain tumors

...Associate Editor Yale School of Medicine Yale University Institut National de la Sante et de la Recherche Medicale (INSERM) University of Helsinki Howard...
BioCentury | Dec 6, 2019
Targets & Mechanisms

Emerging immuno-oncology mechanisms at ASH 2019

...who achieved remission compared with those who had not ( No. 660 ). Work by University of Helsinki...
...box Allison Johnson, Senior Writer Inarigivir soproxil (sb 9200) American Society of Hematology Northwestern University University Health Network Kumamoto University Harvard Medical School University of Helsinki Technical...
BioCentury | Sep 13, 2019
Emerging Company Profile

Valo: adding tumor antigens to oncolytic viruses

...viruses to display tumor antigens. Scientific founder and board member Vincenzo Cerullo, a professor at University of Helsinki...
...Peptide-coated Conditionally Replicating Adenovirus (PeptiCRAd),which was Valo’s core IP when it spun out of the University of Helsinki...
...viral surfaces Disease focus: Cancer Clinical status: Preclinical Founded: 2016 by Vincenzo Cerullo University collaborators: University of Helsinki...
BioCentury | Aug 8, 2019
Distillery Therapeutics

Activating WNT signaling to regenerate aged or damaged intestinal epithelium

...10, 2019 doi:10.1038/s41586-019-1383-0 CONTACT: Pekka Katajisto, University of Helsinki, Helsinki, Finland; Karolinksa Institute, Stockholm, Sweden email: pekka.katajisto@helsinki.fi Claire Quang University of Helsinki Notum...
BioCentury | Aug 8, 2018
Distillery Therapeutics

Cardiovascular

...published online June 25, 2018 doi:10.1073/pnas.1722317115 CONTACT: Pipsa Saharinen, University of Helsinki, Helsinki, Finland email: pipsa.saharinen@helsinki.fi Chris Lieu University of Helsinki Integrin...
BioCentury | Jul 20, 2018
Company News

U of Helsinki grants Herantis rights to a non-invasive CDNF approach

...PD patients. University of Helsinki, Helsinki, Finland Herantis Pharma plc (HSE:HRTIS), Helsinki, Finland Business: Neurology Shannon Lehnbeuter Herantis Pharma plc University of Helsinki Cerebral...
BioCentury | Jun 12, 2018
Preclinical News

Investors skittish again over preclinical CRISPR studies

...10 (LCA10). Allison Johnson CRISPR Therapeutics AG Editas Medicine Inc. Intellia Therapeutics Inc. Karolinska Institute Novartis Institute for Biomedical Research University of Cambridge University of Helsinki p53...
Items per page:
1 - 10 of 50